Search Results 671-680 of 14971 for Dental zirconium

  1. Throat cancer - Doctors and departments - Mayo Clinic

    Dental Specialties · Head and Neck Cancer Center · Laryngology and Voice Disorders · Oncology (Medical) · Oral and Maxillofacial Surgery · Oropharynx Cancer ...

  2. Erlotinib with or without Bevacizumab in Treating Patients with Stage IV Non-Small Cell Lung Cancer with EGFR Mutations - Mayo Clinic

    ... oral or parenteral anticoagulants or thrombolytic agent for therapeutic purposes * Note: Prophylactic use of anticoagulants is allowed; Serious non-healing ...

  3. Clinical Trials

    Mayo Clinic's clinical trials related to epilepsy include studies of new drugs in development, neurostimulation, surgical interventions, and imaging techniques ...

  4. Efficacy and Safety of Maribavir in Transplant Recipients With Cytomegalovirus (CMV) Infections That Are Refractory or Resistant to Treatment - Mayo Clinic

    ... oral/enteral medication. Have known hypersensitivity to the active substance or to an excipient for a study treatment. Have tissue invasive CMV disease with ...

  5. Head and neck cancers - Doctors and departments - Mayo Clinic

    Oral and Maxillofacial Surgery · Otolaryngology (ENT)/Head and Neck Surgery · Pediatric and Adolescent Medicine · Pediatric Hematology/Oncology · Pediatric ...

  6. Detection of Circulating Biomarkers (Circulating Tumor Cells and Circulating Tumor DNA) in Patients with Head and Neck Carcinoma following Surgical Intervention - Mayo Clinic

    Diagnosed with cancer of the oral cavity, oropharynx, larynx or hypopharynx: Any patient with lymphopathy;; Stage T2 cancer and above if no lymph node ...

  7. Head and neck cancers - Doctors and departments - Mayo Clinic

    Oral and Maxillofacial Surgery · Otolaryngology (ENT)/Head and Neck Surgery · Pediatric and Adolescent Medicine · Pediatric Hematology/Oncology · Pediatric ...

  8. Robots Lend Helping Hand in Treating Throat Cancers - Mayo Clinic News Network

    The Mayo Clinic study found that transoral robotic surgery for treatment of oral cancers, conducted through the patient's mouth, provided excellent results ...

  9. A Study to Evaluate Optimal Target of Activated Clotting Time During Percutaneous Coronary Intervention and Outcomes - Mayo Clinic

    Use of warfarin (vitamin K antagonist) or direct oral anticoagulant. Patients on LMWH bridging strategy. PCI within prior 30 days. Planned use of ...

  10. An Extension Study to Assess the Safety of the Use of Cannabidiol in Children and Young Adults with Dravet or Lennox-Gastaut Syndromes - Mayo Clinic

    ... oral contraception, double barrier, intra uterine device, during the study and for three months thereafter (however a male condom should not be used in ...